Product Images Cabenuva
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 50 images provide visual information about the product associated with Cabenuva NDC 49702-240 by Viiv Healthcare Company, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Cabotegravir chemical structure - cabenuva spl graphic 01
Rilpivirine chemical structure - cabenuva spl graphic 02
Cabenuva Instructions for Use 400mg_600mg Kit - cabenuva spl graphic 03
These are the instructions for administering CABENUVA, which is a combination of Cabotegravir and Rilpivirine. It is an injectable suspension used only for gluteal intramuscular use. These instructions are intended for healthcare professionals only.*
Contents of Kit - cabenuva spl graphic 04
Figure A - cabenuva spl graphic 05
This text implies a suggestion to conduct a routine check of the expiration date of medicine. It is advisable to regularly monitor the expiration date of medicines in order to ensure their efficacy and safety.*
Figure B - cabenuva spl graphic 06
Figure C - cabenuva spl graphic 07
Figure D - cabenuva spl graphic 08
Figure E - cabenuva spl graphic 09
Figure F - cabenuva spl graphic 10
Figure G - cabenuva spl graphic 11
Figure H - cabenuva spl graphic 12
Figure I - cabenuva spl graphic 13
Figure J - cabenuva spl graphic 14
Figure K - cabenuva spl graphic 15
Figure L - cabenuva spl graphic 16
Figure M - cabenuva spl graphic 17
Figure N - cabenuva spl graphic 18
Figure O - cabenuva spl graphic 19
Figure P - cabenuva spl graphic 20
Figure Q - cabenuva spl graphic 21
Figure R - cabenuva spl graphic 22
Figure S - cabenuva spl graphic 23
Figure T - cabenuva spl graphic 24
This text is not enough to provide a useful description of anything. It only mentions "Sharps disposal container" which could refer to various types of containers used for disposing of medical needles or other sharps. More context or information is needed.*
Figure U - cabenuva spl graphic 25
Cabenuva Instructions for Use 600mg_900mg Kit - cabenuva spl graphic 26
The text appears to be instructions for use of CABENUVA, which is a combination of Cabotegravir and Rilpivirine, administered as extended-release injectable suspension for gluteal intramuscular use only. It is meant for healthcare professionals' administration only.*
Contents of Kit - cabenuva spl graphic 27
The text provides a list of items related to injections, including cabotegravir and rilpivirine vials, vial adapters and caps, rubber stoppers, syringes, syringe labels, injection needles, and needle caps. It can be useful for medical professionals who need to administer injections.*
Figure A - cabenuva spl graphic 28
The given text is a brief instruction that advises the reader to check the expiration date of their medicine. No further information on the context or purpose is provided.*
Figure B - cabenuva spl graphic 29
Figure C - cabenuva spl graphic 30
Figure D - cabenuva spl graphic 31
Figure E - cabenuva spl graphic 32
Figure F - cabenuva spl graphic 33
Figure G - cabenuva spl graphic 34
Figure H - cabenuva spl graphic 35
Figure I - cabenuva spl graphic 36
Figure J - cabenuva spl graphic 37
Figure K - cabenuva spl graphic 38
Figure L - cabenuva spl graphic 39
Figure M - cabenuva spl graphic 40
Figure N - cabenuva spl graphic 41
Figure O - cabenuva spl graphic 42
Figure P - cabenuva spl graphic 43
Figure Q - cabenuva spl graphic 44
Figure R - cabenuva spl graphic 45
Figure S - cabenuva spl graphic 46
Figure T - cabenuva spl graphic 47
Figure U - cabenuva spl graphic 48
Cabenua 400 mg-600mg carton - cabenuva spl graphic 49
CABENUVA is a co-packaged, prescription-only injectable suspension for intramuscular use only by healthcare professionals. It contains cabotegravir extended-release and rilpivirine extended-release in the ratio of 400 mg/2 mL with 600 mg/2 mL, respectively. The pack also includes one vial each of cabotegravir and rilpivirine, vial adapters, syringes, injection needles, and syringe labels. The product should be stored at 2°C to 8°C (36°F to 46°F) and not be frozen. Any unused portion should be discarded. For more information about the use of CABENUVA, please refer to the Prescribing Information and Patient Information.*
Cabenua 600 mg-900mg carton - cabenuva spl graphic 50
Cabenuva is an injectable suspension medication packaged with two single-dose vials (cabotegravir extended-release and rilpivirine extended-release), vial adapters, syringes, and injection needles. It is intended for gluteal intramuscular use only, and must be administered by a healthcare professional. The kit contains 600 mg/3 mL of cabotegravir and 900 mg/3 mL of rilpivirine. It should be stored at 2°C to 8°C, and unused portions should be discarded.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.